Uni-Bio Science Group Limited
UNBSF
$0.004
$0.000.00%
OTC PK
| 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | 06/30/2023 | |
|---|---|---|---|---|---|
| Net Income | 56.60% | 67.03% | 84.07% | 325.84% | 1,004.71% |
| Total Depreciation and Amortization | 60.39% | 23.15% | -3.77% | -27.70% | -45.83% |
| Total Amortization of Deferred Charges | -4.26% | -4.26% | -4.26% | -4.01% | -4.24% |
| Total Other Non-Cash Items | -214.21% | -139.06% | -47.10% | 127.63% | 116.67% |
| Change in Net Operating Assets | 180.50% | 180.50% | 180.50% | 87.12% | -87.47% |
| Cash from Operations | 76.79% | 87.76% | 103.35% | 461.10% | 473.35% |
| Capital Expenditure | -110.55% | -110.55% | -110.55% | -139.52% | -234.89% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -14.29% | 500.00% |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -113.06% | -250.05% | -1,367.88% | -291.61% | -200.16% |
| Cash from Investing | -111.93% | -138.78% | -182.06% | -492.83% | -742.93% |
| Total Debt Issued | 199.63% | 199.63% | 199.63% | 166.14% | 99.37% |
| Total Debt Repaid | -292.69% | -292.69% | -292.69% | -318.57% | -464.75% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -13.11% | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 425.54% | 241.39% | 89.35% | 11.77% | -1,358.80% |
| Cash from Financing | 1,098.29% | 1,004.05% | 854.57% | 540.06% | 115.03% |
| Foreign Exchange rate Adjustments | -33.42% | -46.66% | -68.59% | -113.92% | -193.21% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 319.03% | 213.33% | 112.86% | 5,718.98% | 190.33% |